Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Emily K. Wright"'
Autor:
Elizabeth A. Spencer, Marla C. Dubinsky, Michael A. Kamm, Maria Chaparro, Paolo Gionchetti, Fernando Rizzello, Javier P. Gisbert, Emily K. Wright, Julien D. Schulberg, Amy L. Hamilton, Dermot P. B. McGovern, Thierry Dervieux
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/4fd9de70c804409e9437ad5e101a7db8
Autor:
Elizabeth A. Spencer, Marla C. Dubinsky, Michael A. Kamm, Maria Chaparro, Paolo Gionchetti, Fernando Rizzello, Javier P. Gisbert, Emily K. Wright, Julien D. Schulberg, Amy L. Hamilton, Dermot P. B. McGovern, Thierry Dervieux
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionWe evaluated baseline Clearance of anti-tumor necrosis factors and human leukocyte antigen variant (HLA DQA1*05) in combination as poor prognostic factors (PPF) of pharmacokinetic (PK) origin impacting immune response (formation of antidr
Externí odkaz:
https://doaj.org/article/22a1d851031241dcae3bcd681f13b292
Publikováno v:
Case Reports in Gastroenterology, Vol 17, Iss 1, Pp 155-159 (2023)
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis of small to medium vessels. Gastrointestinal involvement is uncommon and is associated with higher mortality. Treatment is based on empiric evidence. In this article,
Externí odkaz:
https://doaj.org/article/2ec5770651634629a957743ce2d4131c
Autor:
Amy L. Hamilton, Michael A. Kamm, Peter De Cruz, Emily K. Wright, Hai Feng, Josef Wagner, Joseph J. Y. Sung, Carl D. Kirkwood, Michael Inouye, Shu-Mei Teo
Publikováno v:
Gut Microbes, Vol 11, Iss 6, Pp 1713-1728 (2020)
Background Microbial factors are likely to be involved in the recurrence of Crohn’s disease (CD) after bowel resection. We investigated the luminal microbiota before and longitudinally after surgery, in relation to disease recurrence, using 16S met
Externí odkaz:
https://doaj.org/article/7d7e6ad7acfc4dcb9b2e52307e404810
Autor:
Khue M. Nguyen, Vandita Y. Mattoo, Sara Vogrin, Chamara Basnayake, William R. Connell, Nik S. Ding, Emma Flanagan, Michael A. Kamm, Mark Lust, Ola Niewiadomski, Julien D. Schulberg, Emily K. Wright
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics. 48:271-279
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0844bdb681d21d8b28a01e3be4198dd
https://doi.org/10.1007/s13318-023-00824-w
https://doi.org/10.1007/s13318-023-00824-w
Autor:
Ralley E. Prentice, Emily K. Wright, Emma Flanagan, Michael A Kamm, Rimma Goldberg, Alyson L. Ross, Megan Burns, Sally J. Bell
Publikováno v:
European Journal of Gastroenterology & Hepatology. 35:609-612
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::878699c76abac049ee59966fd939ff62
https://doi.org/10.1097/meg.0000000000002538
https://doi.org/10.1097/meg.0000000000002538
Publikováno v:
Journal of Crohn's and Colitis. 16:1797-1807
Introduction Crohn’s disease recurs after intestinal resection. This study evaluated accuracy of a new blood test, the Endoscopic Healing Index [EHI], in monitoring for disease recurrence. Methods Patients enrolled in the prospective POCER study [N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::162e59a119f7b5eec620dec6915c1995
https://doi.org/10.1093/ecco-jcc/jjac076
https://doi.org/10.1093/ecco-jcc/jjac076
Publikováno v:
ANZ Journal of Surgery.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90802637d2dee9cd9b96296a828c518e
https://doi.org/10.1111/ans.18490
https://doi.org/10.1111/ans.18490
Autor:
Ralley E. Prentice, Emily K. Wright, Emma Flanagan, Rod W. Hunt, Gregory T. Moore, Claudia A. Nold-Petry, Sally J. Bell, Marcel F. Nold, Rimma Goldberg
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::706f8cb6c8d88cb61562fd4609c947f6
https://doi.org/10.1016/j.jcmgh.2023.03.005
https://doi.org/10.1016/j.jcmgh.2023.03.005
Autor:
Emma Flanagan, Ralley Prentice, Emily K. Wright, Peter R. Gibson, Alyson L. Ross, Jakob Begun, Miles P. Sparrow, Rimma Goldberg, Ourania Rosella, Megan Burns, Katerina V. Kiburg, Sally J. Bell
Publikováno v:
Alimentary Pharmacology & Therapeutics. 55:700-704
Ustekinumab is increasingly used in pregnant women with inflammatory bowel disease (IBD). Existing safety data are reassuring, but the stability of ustekinumab levels in pregnancy, degree of transfer to the infant and time to infant clearance are unk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39c330182441a263b00cc30f762f572e
https://doi.org/10.1111/apt.16739
https://doi.org/10.1111/apt.16739